| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA3561990 | F | PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 2, green channel. (Class of assay: confirmatory) | 2,189 | assay format | PubChem BioAssays | |||
| 2. | ALA3561991 | F | PubChem BioAssay. Increased HeLa cells with 2N DNA content-IC50. (Class of assay: confirmatory) | 181 | cell-based format | PubChem BioAssays | |||
| 3. | ALA3561996 | F | PubChem BioAssay. SW480 viability from Cell TiterGlo-IC50. (Class of assay: confirmatory) | 233 | assay format | PubChem BioAssays | |||
| 4. | ALA3562021 | F | PubChem BioAssay. RKO viability from Cell TiterGlo-IC50. (Class of assay: confirmatory) | 233 | assay format | PubChem BioAssays | |||
| 5. | ALA3562024 | F | PubChem BioAssay. VEGF stimulated ADSC/ECFC co-culture nuclear area decrease (viability)-IC50. (Class of assay: confirmatory) | 369 | assay format | PubChem BioAssays | |||
| 6. | ALA3562026 | F | PubChem BioAssay. Decreased HeLa cell count-IC50. (Class of assay: confirmatory) | 180 | cell-based format | PubChem BioAssays | |||
| 7. | ALA3562027 | F | PubChem BioAssay. HCT116 viability from Cell TiterGlo-IC50. (Class of assay: confirmatory) | 232 | assay format | PubChem BioAssays | |||
| 8. | ALA3562043 | F | PubChem BioAssay. VEGF stimulated ADSC/ECFC co-culture CD31-stained tube area decrease-IC50. (Class of assay: confirmatory) | 368 | assay format | PubChem BioAssays | |||
| 9. | ALA3562069 | F | PubChem BioAssay. Colo320 viability from Cell TiterGlo-IC50. (Class of assay: confirmatory) | 233 | assay format | PubChem BioAssays | |||
| 10. | ALA3562115 | F | PubChem BioAssay. Increased HeLa cells in S-phase-IC50. (Class of assay: confirmatory) | 138 | cell-based format | PubChem BioAssays | |||
| 11. | ALA3562119 | F | PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 green channel. (Class of assay: confirmatory) | 2,170 | assay format | PubChem BioAssays | |||
| 12. | ALA3562120 | F | PubChem BioAssay. Increased HeLa cells with 4N DNA content-IC50. (Class of assay: confirmatory) | 183 | cell-based format | PubChem BioAssays | |||
| 13. | ALA3562123 | F | PubChem BioAssay. HT-29 viability from Cell TiterGlo-IC50. (Class of assay: confirmatory) | 228 | assay format | PubChem BioAssays | |||
| 14. | ALA3562124 | F | PubChem BioAssay. DLD-1 viability from Cell TiterGlo-IC50. (Class of assay: confirmatory) | 231 | assay format | PubChem BioAssays | |||
| 15. | ALA3562139 | F | PubChem BioAssay. Increased chromatin condensation in HeLa cells-IC50. (Class of assay: confirmatory) | 183 | cell-based format | PubChem BioAssays | |||
| 16. | ALA3562146 | F | PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 ratio channel. (Class of assay: confirmatory) | 1,812 | assay format | PubChem BioAssays | |||
| 17. | ALA3562152 | F | PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen2, ratio channel. (Class of assay: confirmatory) | 1,822 | assay format | PubChem BioAssays | |||
| 18. | ALA3987222 | B | Compound was evaluated for the inhibition of human FECH at 10uM | Homo sapiens | 400 | single protein format | MMV Pathogen Box | ||
| 19. | ALA3987223 | B | Compound was evaluated for the inhibition of human HMBS at 100uM | Homo sapiens | 400 | assay format | MMV Pathogen Box | ||
| 20. | ALA4296184 | F | Antibacterial activity against Staphylococcus aureus MRSA ATCC 43300 (CO-ADD:GP_020); MIC in CAMBH media, using NBS plates, by OD(600) | Staphylococcus aureus | 4,588 | organism-based format | CO-ADD antimicrobial screening data |
The page will load shortly, Thanks for your patience!